Customize your experience
You decide what information you want to see on your Sanofi Campus
More about science
Choose a therapeutic area to find related scientific content
Allergic Rhinitis
Asthma
Atopic Dermatitis
Cardiovascular
Diabetes
Eosinophilic Esophagitis
Multiple Sclerosis
Nasal Polyps
Oncology and Rare Blood Disorders
Prurigo Nodularis
Rare Diseases
Vaccines
Latest trends
Explore the most popular scientific articles and videos among Campus Sanofi users
2019 ESC Guidelines for Acute Pulmonary Embolism
A Meningitis Survivor: Daniel Advocates for Prevention
A promising biomarker in MS: Neurofilament light chain
APSC Consensus Recommendations on Dyslipidemia
ASH 2019 Guidelines for Surgical Prophylaxis
ATTD 2021: Patients’ profiles for digital tools
ATTD 2021: Technology supporting initiation, titration and intensification
About Type 2 Inflammation - Atopic Dermatitis
About Type 2 Inflammation - Nasal Polyps
About Type 2 Inflammation – Asthma
Achievement of ESC/EAS LDL-C Treatment Goals After an ACS with Statin and Alirocumab
Achievement of lipid modification goals with Statins & Ezetimibe
Events
Stay up to date and register for the latest events and view webinar recordings
Diatour Programme
Diatour Inquiry Form
What is Epilepsy
Investigation and Treatment of Epilepsy
Venous Thromboembolism Burden
Sanofi Thrombosis Summit
Insulin@100 Live Webinar. Discovery. Transformation. Legacy.
Diabetes Guidelines in Ramadan
Ultimate Need for Intensification
Roadmap to antimicrobial prescribing
KSUMC Aubagio experience
Dyslipidemia Webinars: Optimizing Dyslipidemia management
Support for your patients
Discover the selection of support materials for patients from different therapeutic areas
Act Now for ACS Patients
Hyperglycemia
Hypoglycemia
About Diabetes
SCORAD
Treat Early
ADCT Tool
EASI Calculator
Identify Your Patient
ESC/EAS Guidelines
ACS EuroPath Project
Insulin and Other Medications Dose Adjustments for Type 1 and 2 Diabetes in Ramadan
Sanofi in News
Discover headline news on how Sanofi is engaged with the medical community
Ministry of Health organizes "KiDS" program at Expo 2020 Dubai to promote diabetes awareness at schools
Sanofi signs multi-pronged partnership with Dasman Diabetes Institute to intensify diabetes prevention in Kuwait
Saudi Health Council, Sanofi partner to boost diabetes studies and research in the kingdom
Our Products
Amaryl®
Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.
Aprovel®
Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II used to Effectively control Hypertension to normal Rates.
Aubagio®
AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)
Clexane®
Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.
Depakine®
Valproate and its valproic acid, sodium valproate, and valproate semisodium forms are medications primarily used to treat epilepsy.
Dupixent®
Is a fully human monoclonal antibody with multiple indications in different therapeutic areas.
Lantus®
Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.
Lemtrada®
Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).
Plavix®
Clopidogrel is an inhibitor of platelet aggregation administered orally and indicated for Secondary prevention of atherothrombotic events.
Praluent®
Alirocumab is a fully human IgG1 monoclonal antibody. It’s a PCSK9 inhibitor that is administered subcutaneously.
Sarclisa®
Isatuximab is an immunoglobulin G1 (IgG1) monoclonal antibody (mAb) for the treatment of adult patients with relapsed and refractory multiple myeloma in combined regimens.
Soliqua®
Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.
Tavanic®
Levofloxacin is used in adults for the treatment of infections. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.
Zympass®
Combination of Rosuvastatin Calcium & Ezetimibe used as adjunct to diet for treatment of Primary Hypercholesterolemia or Homozygous Familial Hypercholesterolemia.
▼This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.
YOU WILL NOW BE LEAVING THE SITE
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.